CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-20 | SEYMOUR TAMARA A Director | Purchase | +200 | $4.87 | $974 | 200 |
| 2022-05-18 | Plooster Matthew R Director | Purchase | +695 | $4.94 | $3K | 3,195 |
| 2022-05-18 | Plooster Matthew R Director | Purchase | +915 | $4.95 | $5K | 4,110 |
| 2022-05-18 | Plooster Matthew R Director | Purchase | +3,051 | $4.96 | $15K | 7,161 |
| 2022-05-18 | Plooster Matthew R Director | Purchase | +339 | $4.97 | $2K | 7,500 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +300 | $4.90 | $1K | 3,585 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +100 | $4.90 | $490 | 3,685 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +400 | $4.91 | $2K | 4,085 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +400 | $4.91 | $2K | 4,485 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +1,767 | $4.92 | $9K | 6,252 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +1,700 | $4.93 | $8K | 7,952 |
| 2022-05-18 | Pascoe Richard W Executive Chairman | Purchase | +333 | $4.94 | $2K | 8,285 |
| 2022-05-18 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +1,200 | $5.00 | $6K | 6,440 |
| 2022-02-01 | Sangiovanni Timothy J. VP, Corporate Controller | Grant or award · Stock Option (right to buy) | +50,092 | 50,092 | ||
| 2022-02-01 | Guenther Sven EVP, Research & Development | Grant or award · Stock Option (right to buy) | +83,486 | 83,486 | ||
| 2022-02-01 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Stock Option (right to buy) | +83,486 | 83,486 | ||
| 2022-02-01 | Pascoe Richard W Executive Chairman | Grant or award · Stock Option (right to buy) | +127,286 | 127,286 | ||
| 2022-02-01 | Mickle Travis C President & CEO | Grant or award · Stock Option (right to buy) | +267,156 | 267,156 | ||
| 2021-12-01 | Plooster Matthew R Director | Grant or award | +2,500 | $8.44 | $21K | 2,500 |
| 2021-11-30 | Pascoe Richard W Executive Chairman | Purchase | +1,500 | $7.88 | $12K | 3,285 |
Page 10 of 16 · 319 trades